Trials / Conditions / High Grade Serous Adenocarcinoma of Ovary
High Grade Serous Adenocarcinoma of Ovary
7 registered clinical trials studyying High Grade Serous Adenocarcinoma of Ovary — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Study of Sovilnesib in Subjects With Ovarian Cancer NCT06084416 | Volastra Therapeutics, Inc. | Phase 1 |
| Unknown | Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARP NCT06161272 | Guangxi Medical University | Phase 2 |
| Recruiting | A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer NCT05902988 | Volastra Therapeutics, Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer NCT06063070 | Sun Yat-sen University | Phase 2 |
| Active Not Recruiting | Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors NCT05858736 | OncoC4, Inc. | Phase 1 |
| Active Not Recruiting | First in Human Study of IMGN151 in Recurrent Gynaecological Cancers NCT05527184 | AbbVie | Phase 1 |
| Active Not Recruiting | ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer NCT05446298 | OncoC4, Inc. | Phase 2 |